Allspring Global Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Allspring Global Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.8M	Sell	1,458,911 -205,635	-12%	-$6.85M	0.07%	307
2026 Q1	$50.4M	Sell	1,664,546 -159,581	-9%	-$5.13M	0.08%	282
2025 Q4	$56.5M	Sell	1,824,127 -114,603	-6%	-$2.82M	0.09%	251
2025 Q3	$38.9M	Sell	1,938,730 -4,028,774	-68%	-$70.8M	0.06%	363
2025 Q2	$99.3M	Sell	5,967,504 -316,184	-5%	-$5.1M	0.17%	151
2025 Q1	$96.1M	Buy	6,283,688 +5,186,592	+473%	+$92.6M	0.17%	144
2024 Q4	$23.4M	Buy	1,097,096 +1,045,305	+2,018%	+$19M	0.04%	490
2024 Q3	$933K	Sell	51,791 -10,619	-17%	-$186K	﹤0.01%	1348
2024 Q2	$1.01M	Buy	62,410 +25,657	+70%	+$395K	﹤0.01%	1335
2024 Q1	$519K	Buy	36,753 +7,763	+27%	+$97.9K	﹤0.01%	1522
2023 Q4	$303K	Buy	28,990 +12,882	+80%	+$120K	﹤0.01%	1606
2023 Q3	$164K	Buy	+16,108	New	+$150K	﹤0.01%	1817

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Allspring Global Investments's TEVA Position: Q2 2026 in Review

Allspring Global Investments reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 12% in Q2 2026, selling an estimated $6.85M and leaving 1,458,911 shares worth $48.8M. The position accounts for 0.07% of the portfolio, ranked #307.

Allspring Global Investments first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $99.3M in Q2 2025. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Allspring Global Investments held 1,458,911 shares of Teva Pharmaceutical Industries Limited worth $48.8M as of Q2 2026.
Allspring Global Investments sold 205,635 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $6.85M.
Teva Pharmaceutical Industries Limited made up 0.07% of Allspring Global Investments's portfolio in Q2 2026, its #307 holding.
Allspring Global Investments first reported a position in Teva Pharmaceutical Industries Limited in Q3 2023 and has held it in 12 quarters since.
Allspring Global Investments's Teva Pharmaceutical Industries Limited position peaked at $99.3M in Q2 2025.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.